11.07.2015 Views

Verteporfin photodynamic therapy for neovascular age-related ...

Verteporfin photodynamic therapy for neovascular age-related ...

Verteporfin photodynamic therapy for neovascular age-related ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

146 Appendix 1Appendix 5:Protocol <strong>for</strong> logMAR visual acuity assessment andrefractionStandardising visual acuity testing is the key to obtaining repeatable and reliablemeasurements. The procedure described below has been developed and refined from anumber of previously conducted clinical trials including the MPS studies, SFRADS andTAP/VIP.• Acuity testing should preferably be undertaken in dedicated facilities using chartswith standardised and uni<strong>for</strong>m lighting.• The testing distances should be accurately marked out and the procedure followedshould be identical from one patient to the next and when the patient returns <strong>for</strong>subsequent visits.• While equipment and light bulbs may be replaced as required every attempt must bemade to keep conditions as unchanged and as standardised as possible.1 ETDRS LogMAR Visual Acuity Charts• There are a number of ETDRS charts. For the purposes of the cohort study onlyCharts 1 and 2 and Chart R are needed.• Chart R is used <strong>for</strong> refraction, and <strong>for</strong> recording presenting BDVA (see 7 below).• After refraction is complete Charts 1 and 2 are used <strong>for</strong> testing the right and left eyerespectively.• Each line has 5 uni<strong>for</strong>mly sized and spaced letters which decrease progressively insize from the top most line.LogMAR charts were developed and popularised by Bailey and Lovie and hence they aresometimes referred to as Bailey Lovie Charts. The visual angle is largest with the largestletters. The advant<strong>age</strong> of these charts is that there is a geometric progression of the visualangle with a doubling or a halving with every 3 line change. There<strong>for</strong>e calculation of thevisual angle is very simple and allowances are made <strong>for</strong> the testing distance.• The charts may be standardised <strong>for</strong> testing at any distance, provided the appropriateconversions are clearly understood.• Changing the testing distance simply extends the range of acuity the chart can test.• Thus, <strong>for</strong> example, when used at a distance of 4M the acuity range is -0.3 logMAR to1.0.• By moving the chart to 2M, the range becomes 0.0 logMAR to 1.3.• When testing is undertaken at 1M, acuities as poor as 1.6 can be assessed.• Although standardised <strong>for</strong> the 4M distance, the chart can be easily used at 2M or 1M.• In order to obtain an acuity, when the chart has been used at 2M or 1M the examinersimply adds 15 letters or 0 letters (<strong>for</strong> 2M and 1M respectively) to the number ofletters read at the testing distance. (DPs already familiar with recording logMARacuities in logMAR units may use this <strong>for</strong>mat instead of letters, but must in<strong>for</strong>m theData Man<strong>age</strong>ment Centre that they wish to do so.)• Details of how the results of the tests should be recorded and scored are providedbelow (see 7 and 8). Duplicate <strong>for</strong>ms <strong>for</strong> recording logMAR acuities will be suppliedto DPs.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!